Feng Zhang

Universities Are Arguing Over Genome Editing Technology, But What Does The Law Have to Say About It?

Medicine & Technology May 15, 2015

Three major universities are now engaged in a patent lawsuit to protect their rights to use genome editing technology called CRISPR-Cas9. The fallout will have far more impact than the simple settling of ownership and intellectual property rights, however; experts believe that CRISPR-Cas9 may be the most efficient route toward a ticking off items on a laundry list of amazing biotechnological discoveries.

Feng Zhang

Universities Are Arguing Over Genome Editing Technology, But What Does The Law Have to Say About It?

Most Popular

How Technology Is Changing the Real Estate Industry?

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Nikolay Karpenko Biography, Photo, Career, Accomplishments

China’s Tiangong Space Station to Expand Its Capabilities With New Modules

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission